A purified homogalacturonan-type pectin polysaccharide, AAP50-2, isolated from the traditional Chinese herb Anemarrhena asphodeloides, extended maximum lifespan in wild-type C. elegans from 16 to 25 days at 200 μg/mL — a 56.3% increase. Beyond raw longevity, AAP50-2 improved healthspan metrics: locomotor activity, pharyngeal pumping rate, lipofuscin accumulation (reduced 44–65%), and stress survival (heat: 1.75-fold; oxidative: 2.2-fold). Mechanistically, the compound suppressed mRNA expression of daf-2 (insulin receptor homolog) and age-1 (PI3K homolog), promoted DAF-16/FOXO nuclear translocation, and upregulated downstream effectors sod-3, ctl-1, and hsp-16.2. Mutant rescue assays confirmed pathway dependency.
The insulin/IGF-1 signaling (IIS) axis is one of the most evolutionarily conserved longevity pathways, and DAF-16/FOXO is its canonical transcriptional executor — the same pathway modulated by caloric restriction and metformin in broader research contexts. What distinguishes AAP50-2 is its structural specificity: a linear α-1,4-linked D-galacturonic acid backbone, raising the mechanistic question of whether gut microbiome fermentation intermediates mediate effects in vivo. The dose-response is notably steep and dose-dependent, which is scientifically interesting but demands caution — C. elegans lacks hepatic metabolism, making pharmacokinetic extrapolation to mammals speculative. This is confirmatory for the IIS/FOXO paradigm but genuinely novel for homogalacturonan pectins as a compound class. Human relevance requires mammalian validation.